Xiaoli Yuan Selected Research

Xiaoli Yuan Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 01/2017
3	Inflammation (Inflammations) 11/2023 - 12/2019
2	Congenital Heart Defects (Congenital Heart Defect) 11/2023 - 04/2023
2	Chronic Renal Insufficiency 10/2023 - 11/2022
2	Leukemia 10/2020 - 01/2020
2	Acute Promyelocytic Leukemia 10/2020 - 01/2020
2	Ventricular Fibrillation 08/2019 - 04/2019
2	Heart Arrest (Cardiac Arrest) 08/2019 - 01/2014
1	Insulin Resistance 12/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2023
1	Essential Hypertension 12/2023
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 12/2023
1	Mental Disorders (Mental Disorder) 10/2023
1	Hyperlipidemias (Hyperlipidemia) 11/2022
1	Dyslipidemias (Dyslipidemia) 11/2022
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2022
1	Lung Injury 06/2021
1	COVID-19 06/2020
1	Infections 06/2020
1	Necrosis 12/2019
1	Hepatocellular Carcinoma (Hepatoma) 03/2019
1	Myocardial Infarction 01/2019
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2019
1	Heart Failure 01/2019
1	Multiple Myeloma 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Genomic Instability 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Esophageal Squamous Cell Carcinoma 01/2017
1	Adenocarcinoma of Lung 01/2017
1	Hemorrhage 09/2016
1	Hypochromic Anemia (Chlorosis) 07/2012

Drug/Important Bio-Agent (IBA)

2	Triglycerides (Triacylglycerol)IBA 12/2023 - 11/2022
1	ThrombospondinsIBA 12/2023
1	Biomarkers (Surrogate Marker)IBA 12/2023
1	thrombospondin 2IBA 12/2023
1	HDL CholesterolIBA 12/2023
1	Vitamin D FDA LinkGeneric 12/2023
1	InterleukinsIBA 11/2023
1	Formaldehyde (Formol)FDA Link 11/2023
1	6-bromo-2-naphthyl sulfate (BNS)IBA 10/2023
1	Formaldehyde poisoningIBA 04/2023
1	CholesterolIBA 11/2022
1	TitaniumIBA 03/2022
1	Drug CarriersIBA 03/2022
1	LipopolysaccharidesIBA 06/2021
1	CaspasesIBA 06/2021
1	Insulin-Like PeptidesIBA 06/2021
1	Carrier Proteins (Binding Protein)IBA 06/2021
1	Small Interfering RNA (siRNA)IBA 06/2021
1	Messenger RNA (mRNA)IBA 06/2021
1	Proteins (Proteins, Gene)FDA Link 06/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020
1	Oxidants (Oxidizing Agents)IBA 11/2020
1	HydrogelsIBA 11/2020
1	Peptides (Polypeptides)IBA 11/2020
1	AntigensIBA 10/2020
1	HLA-DR Antigens (HLA-DR)IBA 10/2020
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2020
1	Blood Glucose (Blood Sugar)IBA 06/2020
1	Arsenic Trioxide (Trisenox)FDA Link 01/2020
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020
1	Retinoic Acid Receptor alphaIBA 01/2020
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 12/2019
1	Hematoxylin (Haematoxylon)IBA 12/2019
1	Fetal Proteins (Fetoprotein)IBA 03/2019
1	CateninsIBA 03/2019
1	qishen yiqiIBA 01/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Melphalan (Alkeran)FDA LinkGeneric 01/2018
1	PolymersIBA 01/2017
1	LipidsIBA 01/2017
1	Temozolomide (Temodar)FDA LinkGeneric 01/2017
1	salinomycinIBA 01/2017
1	Long Noncoding RNAIBA 01/2017
1	Coloring Agents (Dyes)IBA 09/2016
1	IntegrinsIBA 01/2014
1	Coffee FDA Link 07/2012

Therapy/Procedure

6	Therapeutics 01/2023 - 01/2017
3	Cardiopulmonary Resuscitation (CPR) 12/2019 - 04/2019
1	Fecal Microbiota Transplantation 11/2022
1	Glycemic Control 06/2020
1	Extracorporeal Membrane Oxygenation 08/2019
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Radiotherapy 01/2017
1	Lymph Node Excision (Lymph Node Dissection) 01/2017
1	Combined Modality Therapy 01/2017
1	Salvage Therapy 01/2017
1	Chemoradiotherapy 01/2017